Ascendis Pharma A/S
ASND
$242.95
$1.240.51%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
4/16/2026
-
MarketBeat
4/16/2026
-
Tickeron - Technical Analysis
4/15/2026
-
MarketBeat
4/15/2026
-
Tickeron - Technical Analysis
4/14/2026
-
MarketBeat
Ascendis Pharma A/S (ASND, $248.55) price may drop as it broke higher Bollinger Band on Apr 13, 2026
4/14/2026
-
Tickeron - Stocks
4/13/2026
-
MarketBeat
4/13/2026
-
MarketBeat
4/12/2026
-
Insider Monkey
4/12/2026
-
MarketBeat
4/11/2026
-
MarketBeat
Ascendis Pharma A/S (ASND, $239.28) Stochastic Oscillator left the overbought zone on April 10, 2026
4/11/2026
-
Tickeron - Technical Analysis
4/10/2026
-
MarketBeat
Ascendis Pharma A/S (ASND, $241.71) price may drop as it broke higher Bollinger Band on Apr 09, 2026
4/10/2026
-
Tickeron - Stocks
4/9/2026
-
MarketBeat
4/9/2026
-
MarketBeat
4/9/2026
-
Tickeron - Technical Analysis
4/9/2026
-
Ticker Report
4/8/2026
-
MarketBeat
4/8/2026
-
Globe Newswire
4/8/2026
-
Globe Newswire
4/7/2026
-
MarketBeat
4/6/2026
-
Globe Newswire
4/6/2026
-
MarketBeat
4/5/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, February 11, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Beginning of May (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
45 70 22 22 44
Address
Tuborg Boulevard 12
Hellerup, 2900
Hellerup, 2900
Country
Year Founded
Business Description
Sector
--
Industry
--
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The...
more